The international group of experts, including Professor John Bridgewater (UCL Cancer Institute), is calling for rapid ...

An international group of cancer experts has called for fundamental change to healthcare approaches for bile duct cancer, which kills three-quarters of patients within a year of diagnosis.

The international group of experts, including Professor John Bridgewater (UCL Cancer Institute), is calling for rapid improvements in diagnosis, treatment and research for cholangiocarcinoma, also ...

Bile duct cancer is medically known as Cholangiocarcinoma. It refers to cancers that arise in the intrahepatic, perihilar, or distal biliary tree. Although it accounts for only about 3% of ...

Academic-center care was independently associated with higher complete oncologic resection rates and improved overall survival versus nonacademic facilities after adjustment for age, comorbidity, and ...

Dr. Shaun P. McKenzie discusses bile duct cancer challenges and why awareness and specialized care help patients get diagnosed earlier and live longer. During Gallbladder and Bile Duct Cancer ...

In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an immunotherapy drug) plus gemcitabine and cisplatin (GemCis, chemotherapy drugs) as the ...

It's Gallbladder and Bile Duct Cancer Awareness month, shining a light on these rare but serious cancers. These cancers are often linked to gallstones, long-term inflammation and certain liver ...

A new study suggests a blood test could distinguish gallbladder cancer from gallstones by tracking changes in metabolites and bile acids.

Survival rates for people with cholangiocarcinoma, a silent but deadly form of cancer originating in the bile ducts, are dismal and a new approach is needed, argues a panel of leading experts ...